Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab

J Thorac Oncol. 2009 Feb;4(2):268-9. doi: 10.1097/JTO.0b013e318195a642.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Cerebral Hemorrhage / chemically induced*
  • Fatal Outcome
  • Humans
  • Intracranial Arteriovenous Malformations / chemically induced*
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab